BioNxt Solutions Completes Significant Funding Round

BioNxt Solutions (TSE:BNXT) has released an update.

BioNxt Solutions has successfully closed the third tranche of its non-brokered private placement, raising $1,400,000 through convertible debentures. The debentures, which carry an 8% annual interest, can be converted into common shares at a set price, with the proceeds aimed at product development and other operational needs.

For further insights into TSE:BNXT stock, check out TipRanks’ Stock Analysis page.